Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Promoter Choice Determines Splice Site Selection in Protocadherin α and γ Pre-mRNA Splicing
2002 StandoutNobel
Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism
2009 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
2002
Formation and Function of the Myofibroblast during Tissue Repair
2007 Standout
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Hidradenitis suppurativa: A comprehensive review
2009 Standout
Structures of hepatitis C virus nonstructural proteins required for replicase assembly and function
2013 StandoutNobel
Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis
2015
Coinfection With HIV-1 and HCV—A One-Two Punch
2009
Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity
2000
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Psoriasis
2021 Standout
Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease–helicase
1999
Psoriasis: Which therapy for which patient
2018
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Clinical management of psoriatic arthritis
2018
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years
2012
Mechanistic review of drug-induced steatohepatitis
2015
Psoriasis
2015 Standout
Determinants for Membrane Association of the Hepatitis C Virus RNA-dependent RNA Polymerase
2001 StandoutNobel
Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study
2013
Chronic hepatitis B
2007 Standout
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
2005 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
THE MOLECULAR BIOLOGY OF HEPATITIS C VIRUS
1999
A Myriad of Pathways to NASH
2012
Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein
2013 StandoutNobel
The global NAFLD epidemic
2013 Standout
The Hepatitis C Virus Nonstructural Protein 4B Is an Integral Endoplasmic Reticulum Membrane Protein
2001 StandoutNobel
Hidradenitis suppurativa
2020 Standout
Guidelines of care for the management of psoriasis and psoriatic arthritis
2008
Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients
1999
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Cadherins and tissue formation: integrating adhesion and signaling
1999
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Psoriasis
2016
Hepatitis B: An important public health issue
2000
Cadherins in the central nervous system
2000
Autoimmunity in Alzheimer’s disease: increased levels of circulating IgGs binding Aβ and RAGE peptides
2004
Taming a beast: lessons from the domestication of hepatitis C virus
2019 StandoutNobel
RAGE and the pathogenesis of chronic kidney disease
2010
Guidelines of care for the management of psoriasis and psoriatic arthritis
2009
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
New therapeutic strategies for hepatitis C
2002 StandoutNobel
The Myofibroblast
2007 Standout
Replication of hepatitis C virus
2007 StandoutNobel
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Biomarkers of Inflammation and Coagulation Are Associated With Mortality and Hepatitis Flares in Persons Coinfected With HIV and Hepatitis Viruses
2013
Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication
2003 StandoutNobel
Replication of hepatitis C virus
2000
A cis -Acting Replication Element in the Sequence Encoding the NS5B RNA-Dependent RNA Polymerase Is Required for Hepatitis C Virus RNA Replication
2004 StandoutNobel
Myofibroblast Development Is Characterized by Specific Cell-Cell Adherens Junctions
2004
Psoriasis Pathogenesis and Treatment
2019 Standout
Immunization of woodchucks with adjuvanted sHDAg (p24): immune response and outcome following challenge
2003 StandoutNobel
Antiviral Stilbene 1,2-Diamines Prevent Initiation of Hepatitis C Virus RNA Replication at the Outset of Infection
2011 StandoutNobel
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
The Tricuspid Valve
2009
Enzymatic properties of hepatitis C virus NS3-associated helicase
2000
The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication
2007 StandoutNobel
Induction of experimental obstructive cholestasis in mice
2015
Mutations in the Yellow Fever Virus Nonstructural Protein NS2A Selectively Block Production of Infectious Particles
2002 StandoutNobel
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
2002 StandoutNobel
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture
2003 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Inactivation of the β-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development
2001 Standout
Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis
2004 Standout
Hepatitis C Virus Genotype 5a Subgenomic Replicons for Evaluation of Direct-Acting Antiviral Agents
2014 StandoutNobel
Single‐molecule imaging reveals the translocation and DNA looping dynamics of hepatitis C virus NS3 helicase
2017 StandoutNobel
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Works of Peter Rosenberg being referenced
Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-κB activation
2002
Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment
2007
The liver in heart failure
2002
Rapidly progressive fibrosing cholestatic hepatitis-hepatitis C virus in HIV coinfection
2002
Attenuated liver fibrosis after bile duct ligation and defective hepatic stellate cell activation in neural cell adhesion molecule knockout mice
2011
A Potential Role of R-cadherin in Striated Muscle Formation
1997
Advanced glycation end product is implicated in amyloid‐related kidney complications
2005
Hepatitis C: A Hepatologist's Approach to an Infectious Disease
2001
THERAPY WITH NUCLEOSIDE ANALOGUES FOR HEPATITIS B VIRUS INFECTION
1999
Therapies for viral hepatitis
1999